Panel Clears Merck's Vytorin Trial to Continue

A closely watched clinical trial for Merck's cholesterol-lowering blockbuster Vytorin was cleared to proceed by a safety board overseeing the research.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news